PRE-CONFERENCE DAY - Tuesday July 23, 2024

9:00am – 12:00pm | Workshop A

Vaginal Microbiome 101: Reflection of the Fundamental Characteristics & the Latest Research & Developmental Updates

  • Katie Barletta Medical Director US R&D, Ferring Pharmaceuticals
  • Jared Kehe Co-founder and Chief Scientific Officer, Concerto Biociences

Synopsis

This workshop will gather experts to discuss:

  • Reviewing the complexities of the vaginal microbiome with an appreciation of the mechanims of action among the population of microorganism
  • Honing the diversity in microbes across the vaginal microbiome to explore the multifactoral causes behind microbiome imbalance
  • Analyzing the diversity of microbiome populations across ethnicities to support diagnostic understanding and subsequent therapeutic interventions

12:00 pm Lunch & Networking

1:00pm – 4:00pm | Workshop B

Navigating the Women’s Health Investment Landscape to Secure 2024 Funding

Synopsis

This workshop will gather experts to discuss:

  • Illustrating the women’s health biotechnology landscape to understand the current hottest areas of investment
  • Clarifying the desirable traits that women’s health investors are currently seeking which warrants significant investment
  • Foreseeing the increased demand for investment in 2024 and debating how to secure the right investment to advance your pipeline